Harmony Biosciences Holdings, Inc. HRMY Depreciation And Impairment Of Long Lived Assets
Depreciation And Impairment Of Long Lived Assets at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept hrmy:DepreciationAndImpairmentOfLongLivedAssets.
The official record: Harmony Biosciences Holdings, Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s depreciation and impairment of long lived assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s depreciation and impairment of long lived assets?
- Harmony Biosciences Holdings, Inc. (HRMY) reported depreciation and impairment of long lived assets of $372.5K in Q4 2025.
- How has Harmony Biosciences Holdings, Inc.'s depreciation and impairment of long lived assets changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s depreciation and impairment of long lived assets increased by 458.1% year-over-year, from $66.75K to $372.5K.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s depreciation and impairment of long lived assets?
- Over 2 years (2023 to 2025), Harmony Biosciences Holdings, Inc.'s depreciation and impairment of long lived assets has grown at a 70.3% compound annual growth rate (CAGR), from $514K to $1.49M.
- What does depreciation and impairment of long lived assets mean?
- This represents the non-cash expense recognized to account for the wear and tear of tangible assets or the reduction in value of long-lived assets due to impairment. It reflects the systematic allocation of asset costs over their useful lives or the immediate write-down when asset value is no longer recoverable. Investors use this to reconcile net income to operating cash flow by adding back these non-cash charges.